MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two programmes ...
Everything that happens in the NFL has additional context when viewed from a fantasy football perspective. From position battles to injuries and so much more, the news cycle will constantly affect ...